Evidence map›Paper›PMID 29809155›Full record

ArticleeLife2018

Cdc48-like protein of actinobacteria (Cpa) is a novel proteasome interactor in mycobacteria and related organisms.

Michal Ziemski, Ahmad Jomaa, Daniel Mayer, Sonja Rutz, Christoph Giese, Dmitry Veprintsev, Eilika Weber-Ban

Open access · goldAbstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Control of Toxin-Antitoxin Systems by Proteases inFrontiers in molecular biosciences · 2021
    Review
  7. Review
  8. Selective Phenylimidazole-Based Inhibitors of theJournal of medicinal chemistry · 2019
    Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Michal ZiemskiInstitute of Molecular Biology & Biophysics, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-6285-8852
Ahmad JomaaInstitute of Molecular Biology & Biophysics, ETH Zurich, Zurich, Switzerland.
Daniel MayerLaboratory of Biomolecular Research, Paul Scherrer Institute, ETH Zurich, Villigen, Switzerland.
Sonja RutzInstitute of Molecular Biology & Biophysics, ETH Zurich, Zurich, Switzerland.
Christoph GieseInstitute of Molecular Biology & Biophysics, ETH Zurich, Zurich, Switzerland.
Dmitry VeprintsevLaboratory of Biomolecular Research, Paul Scherrer Institute, ETH Zurich, Villigen, Switzerland.
Eilika Weber-BanInstitute of Molecular Biology & Biophysics, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-5773-9274
ETH Zurich · CHPaul Scherrer Institute · CH

Funding

Swiss National Science Foundation 163314
6 · The paper itself

Abstract

Cdc48 is a AAA+ ATPase that plays an essential role for many cellular processes in eukaryotic cells. An archaeal homologue of this highly conserved enzyme was shown to directly interact with the 20S proteasome. Here, we analyze the occurrence and phylogeny of a Cdc48 homologue in

Indexed as

ActinobacteriaAdaptation, PhysiologicalBacterial ProteinsMycobacteriumProteasome Endopeptidase ComplexValosin Containing ProteinBacterial ProteinsProteasome Endopeptidase ComplexValosin Containing ProteinAAA ATPaseactinobacteriabiochemistryCdc48chemical biologymycobacterial ribosomemycobacterium smegmatisstarvation

Identifiers

PMID29809155
PMCPMC6017811
OpenAlexW2806413543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.